Institutions Holding Call Options on Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the call option holders of Arcutis Biotherapeutics, Inc. (ARQT). We have compiled data on the institutions that hold call options on the stock, with a total of 737,700 call options outstanding, which have been reported (via 13F filing form) to have a value of $7.33 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Stem Point Capital LP
New York, NY |
Nov 13, 2024 Q3 2024 |
250,000
calls
|
$2.32 Million
0.0% of portfolio
|
Q3 2024
Reduced 95.0%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
180,000
calls
|
$1.67 Million
0.0% of portfolio
|
N/A
|
|
|
Caption Management, LLC
Oklahoma City, OK |
Nov 14, 2024 Q3 2024 |
105,000
calls
|
$972,300
0.02% of portfolio
|
Q3 2024
Added 41.32%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
89,700
calls
|
$830,622
0.0% of portfolio
|
N/A
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
63,000
calls
|
$583,380
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Myda Advisors LLC
Inwood, NY |
Nov 13, 2024 Q3 2024 |
50,000
calls
|
$463,000
0.11% of portfolio
|
Q3 2024
New holding
|